{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T06:36:28Z","timestamp":1789540588403,"version":"build-2803163510"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001665","name":"ANR","doi-asserted-by":"publisher","award":["ANR-11-BSV8-0019"],"award-info":[{"award-number":["ANR-11-BSV8-0019"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002915","name":"FRM","doi-asserted-by":"publisher","award":["SPF20130526788"],"award-info":[{"award-number":["SPF20130526788"]}],"id":[{"id":"10.13039\/501100002915","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011658","name":"FRISBI","doi-asserted-by":"publisher","award":["ANR-10-INSB-05-01"],"award-info":[{"award-number":["ANR-10-INSB-05-01"]}],"id":[{"id":"10.13039\/501100011658","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.antiviral.2018.12.008","type":"journal-article","created":{"date-parts":[[2018,12,14]],"date-time":"2018-12-14T19:01:17Z","timestamp":1544814077000},"page":"79-89","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Metal chelators for the inhibition of the lymphocytic choriomeningitis virus endonuclease domain"],"prefix":"10.1016","volume":"162","author":[{"given":"Magali","family":"Saez-Ayala","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elsie","family":"Laban Yekwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e9mence","family":"Mondielli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loic","family":"Roux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9681-9309","authenticated-orcid":false,"given":"Fabrice","family":"Bailly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0924-0433","authenticated-orcid":false,"given":"Philippe","family":"Cotelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2295-5783","authenticated-orcid":false,"given":"Dominga","family":"Rogolino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Canard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8351-4992","authenticated-orcid":false,"given":"Fran\u00e7ois","family":"Ferron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karine","family":"Alvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2018.12.008_bib1","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1073\/pnas.1112389109","article-title":"Probing chelation motifs in HIV integrase inhibitors","volume":"109","author":"Agrawal","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2018.12.008_bib2","doi-asserted-by":"crossref","first-page":"8407","DOI":"10.1021\/jm200851g","article-title":"Investigating the role of metal chelation in HIV-1 integrase strand transfer inhibitors","volume":"54","author":"Bacchi","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2018.12.008_bib3","doi-asserted-by":"crossref","first-page":"E35","DOI":"10.1542\/peds.105.3.e35","article-title":"Lymphocytic choriomeningitis virus: reemerging central nervous system pathogen","volume":"105","author":"Barton","year":"2000","journal-title":"Pediatrics"},{"key":"10.1016\/j.antiviral.2018.12.008_bib4","doi-asserted-by":"crossref","first-page":"5138","DOI":"10.1016\/j.ejmech.2011.08.028","article-title":"Synthesis and SAR optimization of diketo acid pharmacophore for HCV NS5B polymerase inhibition","volume":"46","author":"Bhatt","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.antiviral.2018.12.008_bib5","doi-asserted-by":"crossref","first-page":"7717","DOI":"10.1021\/jm8007085","article-title":"Design, synthesis and biological evaluation of a series of 2-hydroxyisoquinoline-1,3(2H,4H)-diones as dual inhibitors of human immunodeficiency virus type 1 integrase and the reverse transcriptase RNase H domain","volume":"51","author":"Billamboz","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2018.12.008_bib6","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.ejmech.2010.11.033","article-title":"2-hydroxyisoquinoline-1,3(2H,4H)-diones as inhibitors of HIV-1 integrase and reverse transcriptase RNase H domain: influence of the alkylation of position 4","volume":"46","author":"Billamboz","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.antiviral.2018.12.008_bib7","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1021\/jm1014692","article-title":"Magnesium chelating 2-hydroxyisoquinoline-1,3(2H,4H)-diones, as inhibitors of HIV-1 integrase and\/or the HIV-1 reverse transcriptase ribonuclease H domain: discovery of a novel selective inhibitor of the ribonuclease H function","volume":"54","author":"Billamboz","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2018.12.008_bib8","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.ejmech.2016.03.083","article-title":"2-hydroxyisoquinoline-1,3(2H,4H)-diones (HIDs) as human immunodeficiency virus type 1 integrase inhibitors: influence of the alkylcarboxamide substitution of position 4","volume":"117","author":"Billamboz","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.antiviral.2018.12.008_bib9","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1021\/ml400009t","article-title":"4-Substituted 2-hydroxyisoquinoline-1,3(2H,4H)-diones as a novel class of HIV-1 integrase inhibitors","volume":"4","author":"Billamboz","year":"2013","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.antiviral.2018.12.008_bib11","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.antiviral.2005.10.008","article-title":"Identification and characterization of potent small molecule inhibitor of hemorrhagic fever New World arenaviruses","volume":"69","author":"Bolken","year":"2006","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2018.12.008_bib12","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.yapd.2009.08.007","article-title":"Lymphocytic choriomeningitis virus: a prenatal and postnatal threat","volume":"56","author":"Bonthius","year":"2009","journal-title":"Adv. Pediatr."},{"key":"10.1016\/j.antiviral.2018.12.008_bib13","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1001\/jama.287.18.2391","article-title":"Hemorrhagic fever viruses as biological weapons: medical and public health management","volume":"287","author":"Borio","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.antiviral.2018.12.008_bib14","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.antiviral.2014.05.007","article-title":"Hepatitis B virus replication is blocked by a 2-hydroxyisoquinoline-1,3(2H,4H)-dione (HID) inhibitor of the viral ribonuclease H activity","volume":"108","author":"Cai","year":"2014","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2018.12.008_bib15","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.poly.2017.03.032","article-title":"Metal-chelating properties and antiviral activity of some 2-hydroxyphenyl amides","volume":"129","author":"Carcelli","year":"2017","journal-title":"Polyhedron"},{"key":"10.1016\/j.antiviral.2018.12.008_bib16","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1021\/mp400482a","article-title":"Metal-chelating 2-hydroxyphenyl amide pharmacophore for inhibition of influenza virus endonuclease","volume":"11","author":"Carcelli","year":"2014","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.antiviral.2018.12.008_bib17","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.antiviral.2005.07.007","article-title":"Antiviral mode of action of a synthetic brassinosteroid against Junin virus replication","volume":"68","author":"Castilla","year":"2005","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2018.12.008_bib18","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.bmc.2011.10.058","article-title":"The design, synthesis and biological evaluations of C-6 or C-7 substituted 2-hydroxyisoquinoline-1,3-diones as inhibitors of hepatitis C virus","volume":"20","author":"Chen","year":"2012","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.antiviral.2018.12.008_bib19","doi-asserted-by":"crossref","first-page":"4494","DOI":"10.1128\/JVI.00103-16","article-title":"Identification and characterization of a novel broad-spectrum virus entry inhibitor","volume":"90","author":"Chou","year":"2016","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.12.008_bib20","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/j.1469-0691.2009.02847.x","article-title":"Influence of climate change on the incidence and impact of arenavirus diseases : a speculative assessment","volume":"6","author":"Clegg","year":"2009","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.antiviral.2018.12.008_bib21","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1177\/1087057106292746","article-title":"Universal screening methods and applications of ThermoFluor","volume":"11","author":"Cummings","year":"2006","journal-title":"J. Biomol. Screen"},{"key":"10.1016\/j.antiviral.2018.12.008_bib22","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.bmcl.2012.11.095","article-title":"Discovery and optimization of potent broad-spectrum arenavirus inhibitors derived from benzimidazole","volume":"23","author":"Dai","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.antiviral.2018.12.008_bib23","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1002\/cmdc.200900273","article-title":"Aryldiketo acids have antibacterial activity against MDR Staphylococcus aureus strains : structural insights based on similarity and molecular interaction fields","volume":"4","author":"Drakulic","year":"2009","journal-title":"ChemMedChem"},{"key":"10.1016\/j.antiviral.2018.12.008_bib25","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.antiviral.2017.04.012","article-title":"Inhibition of hepatitis B virus replication by N-hydroxyisoquinolinediones and related polyoxygenated heterocycles","volume":"143","author":"Edwards","year":"2017","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2018.12.008_bib26","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1128\/AAC.40.5.1304","article-title":"Anti-influenza virus activities of 4-substituted 2,4-dioxobutanoic acid inhibitors","volume":"40","author":"Hastings","year":"1996","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2018.12.008_bib27","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/j.1348-0421.2002.tb02724.x","article-title":"Additional inhibitory effect of tea extract on the growth of influenza A and B viruses in MDCK cells","volume":"46","author":"Imanishi","year":"2002","journal-title":"Microbiol. Immunol."},{"key":"10.1016\/j.antiviral.2018.12.008_bib28","doi-asserted-by":"crossref","first-page":"904","DOI":"10.2460\/javma.2005.227.904","article-title":"The arenaviruses","volume":"227","author":"Jay","year":"2005","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"10.1016\/j.antiviral.2018.12.008_bib29","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.1021\/acs.jmedchem.6b01227","article-title":"Inhibitors of influenza virus polymerase acidic (PA) endonuclease: contemporary developments and perspectives","volume":"60","author":"Ju","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2018.12.008_bib30","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1021\/jm301550c","article-title":"Carbamoyl pyridone HIV-1 integrase inhibitors. 2. Bi- and tricyclic derivatives result in superior antiviral and pharmacokinetic profiles","volume":"56","author":"Kawasuji","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2018.12.008_bib32","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1073\/pnas.44.2.98","article-title":"Application of a theory of enzyme specificity to protein synthesis","volume":"44","author":"Koshland","year":"1958","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2018.12.008_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002831","article-title":"Structural analysis of specific metal chelating inhibitor binding to the endonuclease domain of Influenza pH1N1 (2009) polymerase","volume":"8","author":"Kowalinski","year":"2012","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2018.12.008_bib34","doi-asserted-by":"crossref","first-page":"RRN1052","DOI":"10.1371\/currents.RRN1052","article-title":"Green tea catechins inhibit the endonuclease activity of influenza A virus RNA polymerase","volume":"1","author":"Kuzuhara","year":"2009","journal-title":"PLoS Curr."},{"key":"10.1016\/j.antiviral.2018.12.008_bib35","doi-asserted-by":"crossref","first-page":"10768","DOI":"10.1128\/JVI.00941-08","article-title":"Identification of a broad-spectrum arenavirus entry inhibitor","volume":"82","author":"Larson","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.12.008_bib36","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1038\/aps.2012.80","article-title":"Amelioration of influenza virus-induced reactive oxygen species formation by epigallocatechin gallate derived from green tea","volume":"33","author":"Ling","year":"2012","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.antiviral.2018.12.008_bib37","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ab.2004.04.031","article-title":"Evaluation of fluorescence-based thermal shift assays for the hit identification in drug discovery","volume":"332","author":"Lo","year":"2004","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.antiviral.2018.12.008_bib38","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/978-1-4939-6869-5_8","article-title":"Development of recombinant arenavirus-based vaccines","volume":"1581","author":"Martinez-Sobrido","year":"2017","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.antiviral.2018.12.008_bib39","doi-asserted-by":"crossref","first-page":"6479","DOI":"10.1016\/j.tet.2004.06.030","article-title":"Improved preparation and structural investigation of 4-aryl-4-oxo-2-hydroxy-2-butenoic acids and methyl esters","volume":"60","author":"Maurin","year":"2004","journal-title":"Tetrahedron"},{"key":"10.1016\/j.antiviral.2018.12.008_bib40","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.1016\/j.bmc.2005.12.039","article-title":"Design, synthesis, and anti-integrase activity of catechol-DKA hybrids","volume":"14","author":"Maurin","year":"2006","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.antiviral.2018.12.008_bib41","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJM198601023140104","article-title":"Lassa fever. Effective therapy with ribavirin","volume":"314","author":"McCormick","year":"1986","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2018.12.008_bib42","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1128\/AAC.01219-10","article-title":"T-705 (favipiravir) inhibition of arenavirus replication in cell culture","volume":"55","author":"Mendenhall","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2018.12.008_bib43","doi-asserted-by":"crossref","first-page":"e1342","DOI":"10.1371\/journal.pntd.0001342","article-title":"Effective oral favipiravir (T-705) therapy initiated after the onset of clinical disease in a model of arenavirus hemorrhagic fever","volume":"5","author":"Mendenhall","year":"2011","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.antiviral.2018.12.008_bib44","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1001038","article-title":"The N-terminal domain of the arenavirus L protein is an RNA endonuclease essential in mRNA transcription","volume":"6","author":"Morin","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2018.12.008_bib45","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/0166-3542(93)90008-7","article-title":"Inhibition of the infectivity of influenza virus by tea polyphenols","volume":"21","author":"Nakayama","year":"1993","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2018.12.008_bib46","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.antiviral.2007.12.010","article-title":"PA subunit of RNA polymerase as a promising target for anti-influenza virus agents","volume":"78","author":"Nakazawa","year":"2008","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2018.12.008_bib47","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01289-16","article-title":"Identification and mechanism of action of a novel small-molecule inhibitor of arenavirus multiplication (vol 89, pg 10924, 2015)","volume":"90","author":"Ngo","year":"2016","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.12.008_bib48","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1038\/nprot.2007.321","article-title":"The use of differential scanning fluorimetry to detect ligand interactions that promote protein stability","volume":"2","author":"Niesens","year":"2007","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.antiviral.2018.12.008_bib49","doi-asserted-by":"crossref","first-page":"9633","DOI":"10.1038\/s41598-018-27890-4","article-title":"Characterization of influenza virus variants induced by treatment with the endonuclease inhibitor baloxavir marboxil","volume":"8","author":"Omoto","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.antiviral.2018.12.008_bib50","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1128\/JVI.02275-13","article-title":"Inhibition of arenavirus by A3, a pyrimidine biosynthesis inhibitor","volume":"88","author":"Ortiz-Riano","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.12.008_bib51","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1177\/108705710100600609","article-title":"high-density miniaturized thermal shift assays as a general strategy for drug discovery","volume":"6","author":"Pantoliano","year":"2001","journal-title":"J. Biomol. Screen"},{"key":"10.1016\/j.antiviral.2018.12.008_bib52","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1021\/jm020334u","article-title":"Use of a pharmacophore model to discover a new class of influenza endonuclease inhibitors","volume":"46","author":"Parkes","year":"2003","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2018.12.008_bib53","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1517\/17460441.2016.1153626","article-title":"Novel drug discovery approaches for treating arenavirus infections","volume":"11","author":"Pasquato","year":"2016","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.antiviral.2018.12.008_bib54","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.virol.2011.11.008","article-title":"Evaluation of the anti-arenaviral activity of the subtilisin kexin isozyme-1\/site-1 protease inhibitor PF-429242","volume":"423","author":"Pasquato","year":"2012","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2018.12.008_bib55","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/j.bmc.2006.11.026","article-title":"Synthesis and biological evaluation of novel 5(H)-phenanthridin-6-ones, 5(H)-phenanthridin-6-one diketo acid and polycyclic aromatic diketo acid analogs as new HIV-1 integrase inhibitors","volume":"15","author":"Patil","year":"2007","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.antiviral.2018.12.008_bib56","doi-asserted-by":"crossref","first-page":"3211","DOI":"10.1128\/jvi.69.5.3211-3215.1995","article-title":"5\u2032 termini of Pichinde arenavirus S RNAs and mRNAs contain nontemplated nucleotides","volume":"69","author":"Polyak","year":"1995","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.12.008_bib57","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0168-1702(94)00107-N","article-title":"Analysis of Pichinde arenavirus transcription and replication in human THP-1 monocytic cells","volume":"36","author":"Polyak","year":"1995","journal-title":"Virus Res."},{"key":"10.1016\/j.antiviral.2018.12.008_bib58","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.antiviral.2015.03.003","article-title":"Enzymatic synthesis of acyclic nucleoside thiophosphonate diphosphates: effect of the alpha-phosphorus configuration on HIV-1 RT activity","volume":"117","author":"Priet","year":"2015","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2018.12.008_bib59","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005636","article-title":"Comparative structural and functional analysis of Bunyavirus and Arenavirus cap-snatching endonucleases","volume":"12","author":"Reguera","year":"2016","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2018.12.008_bib60","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1001101","article-title":"Bunyaviridae RNA polymerases (L-protein) have an N-terminal, Influenza-like endonuclease domain, essential for viral cap-dependent transcription","volume":"6","author":"Reguera","year":"2010","journal-title":"PLoS Pathog."},{"issue":"23","key":"10.1016\/j.antiviral.2018.12.008_bib61","doi-asserted-by":"crossref","first-page":"13923","DOI":"10.1128\/JVI.01923-14","article-title":"Exonuclease domain of the Lassa virus nucleoprotein is critical to avoid RIG-I signaling and to inhibit the innate immune response","volume":"88","author":"Reynard","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.12.008_bib62","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1016\/j.ccr.2012.07.006","article-title":"Viral enzymes containing magnesium : metal Binding as a successful strategy in drug design","volume":"256","author":"Rogolino","year":"2012","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.antiviral.2018.12.008_bib63","doi-asserted-by":"crossref","first-page":"LZ5019","DOI":"10.1107\/S2052252518001021","article-title":"Crystal structures of LCMV endonuclease domain complexed with diketo acid ligands","volume":"5","author":"Saez-Ayala","year":"2018","journal-title":"IUCrJ"},{"key":"10.1016\/j.antiviral.2018.12.008_bib64","doi-asserted-by":"crossref","first-page":"4248","DOI":"10.1021\/jm060193m","article-title":"From ligand to complexes: inhibition of human immunodeficiency virus type 1 integrase by beta-diketo acid metal complexes","volume":"49","author":"Sechi","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2018.12.008_bib65","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1177\/095632020801900106","article-title":"Synthesis and evaluation of N-substituted acridones as antiviral agents against haemorrhagic fever viruses","volume":"19","author":"Sepulveda","year":"2008","journal-title":"Antivir. Chem. Chemother."},{"issue":"5","key":"10.1016\/j.antiviral.2018.12.008_bib66","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1002\/jmv.25024","article-title":"Antiviral activity of A771726, the active metabolite of leflunomide, against Junin virus","volume":"90","author":"Sepulveda","year":"2018","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.antiviral.2018.12.008_bib67","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.antiviral.2011.10.007","article-title":"Inhibition of Junin virus RNA synthesis by an antiviral acridone derivative","volume":"93","author":"Sepulveda","year":"2012","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2018.12.008_bib68","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.antiviral.2005.06.010","article-title":"Antiviral effect of catechins in green tea on influenza virus","volume":"68","author":"Song","year":"2005","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2018.12.008_bib69","doi-asserted-by":"crossref","first-page":"3669","DOI":"10.1073\/pnas.1519772113","article-title":"Identification and characterization of influenza variants resistant to a viral endonuclease inhibitor","volume":"113","author":"Song","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2018.12.008_bib70","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1111\/bph.12009","article-title":"anti-infective properties of epigallocatechin-3-gallate (EGCG), a component of green tea","volume":"168","author":"Steinmann","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.antiviral.2018.12.008_bib71","doi-asserted-by":"crossref","first-page":"10524","DOI":"10.1128\/JVI.00832-13","article-title":"Mutational analysis of the binding pockets of the diketo acid inhibitor L-742,001 in the influenza virus PA endonuclease","volume":"87","author":"Stevaert","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.12.008_bib72","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1124\/mol.114.095588","article-title":"An integrated biological approach to guide the development of metal-chelating inhibitors of Influenza virus PA endonuclease","volume":"87","author":"Stevaert","year":"2015","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.antiviral.2018.12.008_bib73","doi-asserted-by":"crossref","first-page":"4640","DOI":"10.1021\/jm500109z","article-title":"Investigation of a novel series of 2-hydroxyisoquinoline-1,3(2H,4H)-diones as human immunodeficiency virus type 1 integrase inhibitors","volume":"57","author":"Suchaud","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2018.12.008_bib74","doi-asserted-by":"crossref","first-page":"5843","DOI":"10.1021\/jm800245z","article-title":"Discovery of raltegravir, a potent, selective orally bioavailable HIV-integrase inhibitor for the treatment of HIV-AIDS infection","volume":"51","author":"Summa","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2018.12.008_bib75","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1128\/AAC.38.12.2827","article-title":"Inhibition of cap (m7GpppXm)-dependent endonuclease of influenza virus by 4-substituted 2, 4-dioxobutanoic acid compounds","volume":"38","author":"Tomassini","year":"1994","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2018.12.008_bib76","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1128\/AAC.40.5.1189","article-title":"A novel antiviral agent which inhibits the endonuclease of influenza viruses","volume":"40","author":"Tomassini","year":"1996","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2018.12.008_bib77","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1016\/j.bmc.2005.02.031","article-title":"Zidampidine, an aryl phosphate derivative of AZT: in vivo pharmacokinetics, metabolism, toxicity, and anti-viral efficacy against hemorrhagic fever caused by Lassa virus","volume":"13","author":"Uckun","year":"2005","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.antiviral.2018.12.008_bib78","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.2298\/JSC0712201V","article-title":"An LFER study of the protolytic equilibria of 4-aryl-2,4-dioxobutanoic acids in aqueous solutions","volume":"72","author":"Verbic","year":"2007","journal-title":"J. Serb. Chem. Soc."},{"key":"10.1016\/j.antiviral.2018.12.008_bib79","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1002\/cjoc.200690203","article-title":"Design, synthesis and Cu2+ recognition of \u03b2-diketoacid and quinoxalone derivatives bearing caffeoyl or galloyl moieties linked by arylamide as potential HIV integrase inhibitors","volume":"24","author":"Xu","year":"2006","journal-title":"Chin. J. Chem."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354218303334?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354218303334?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T07:12:56Z","timestamp":1717225976000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354218303334"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":76,"alternative-id":["S0166354218303334"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2018.12.008","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metal chelators for the inhibition of the lymphocytic choriomeningitis virus endonuclease domain","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2018.12.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}